CD47 and atherosclerosis: In pathological states such as atherosclerosis, myocardial infarction, ischemia–reperfusion injury (IRI), pulmonary hypertension, and heart failure, CD47 is frequently upregulated, thereby impairing efferocytosis, sustaining inflammation, and limiting reparative angiogenesis.